EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review

Su Golder iD, Dongfang Xu, Karen O'Connor, Yunwen Wang, Mahak Batra, Graciela Gonzalez Hernandez

Drug Safety · 2025-04 · 48 (4) · 321-337

DOI: 10.1007/s40264-024-01505-6 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Drug Safety, online erschienen am 09.01.2025. Verfasst von Su Golder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of York, York, YO10 5DD, UK. su.golder@york.ac.uk. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Electronic Health Records, Machine Learning. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: U.S. National Library of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Natural language processing (NLP) and machine learning (ML) techniques may help harness unstructured free-text electronic health record (EHR) data to detect adverse drug events (ADEs) and thus improve pharmacovigilance. However, evidence of their real-world effectiveness remains unclear. OBJECTIVE: To summarise the evidence on the effectiveness of NLP/ML in detecting ADEs from unstructured EHR data and ultimately improve pharmacovigilance in comparison to other data sources. METHODS: A scoping review was conducted by searching six databases in July 2023. Studies leveraging NLP/ML to identify ADEs from EHR were included. Titles/abstracts were screened by two independent researchers as were full-text articles. Data extraction was conducted by one researcher and checked by another. A narrative synthesis summarises the research techniques, ADEs analysed, model performance and pharmacovigilance impacts. RESULTS: Seven studies met the inclusion criteria covering a wide range of ADEs and medications. The utilisation of rule-based NLP, statistical models, and deep learning approaches was observed. Natural language processing/ML techniques with unstructured data improved the detection of under-reported adverse events and safety signals. However, substantial variability was noted in the techniques and evaluation methods employed across the different studies and limitations exist in integrating the findings into practice. CONCLUSIONS: Natural language processing (NLP) and machine learning (ML) have promising possibilities in extracting valuable insights with regard to pharmacovigilance from unstructured EHR data. These approaches have demonstrated proficiency in identifying specific adverse events and uncovering previously unknown safety signals that would not have been apparent through structured data alone. Nevertheless, challenges such as the absence of standardised methodologies and validation criteria obstruct the widespread adoption of NLP/ML for pharmacovigilance leveraging of unstructured EHR data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsElectronic Health RecordsMachine LearningNatural Language ProcessingHumansPharmacovigilance

Autor:innen und Institutionen

  • Department of Health Sciences, University of York, York, YO10 5DD, UK. su.golder@york.ac.uk.
  • Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • William Allen White School of Journalism and Mass Communications, The University of Kansas, Lawrence, KS, USA.
  • Department of Health Sciences, University of York, York, YO10 5DD, UK.

ORCID-Profile: Su Golder

Förderung

  • U.S. National Library of Medicine

Zitieren

APA

Golder, S., Xu, D., O'Connor, K., Wang, Y., Batra, M., & Hernandez, G. G. (2025). Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review. Drug Safety, 48(4), 321-337. https://doi.org/10.1007/s40264-024-01505-6

Vancouver

Golder S, Xu D, O'Connor K, Wang Y, Batra M, Hernandez GG. Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review. Drug Safety. 2025;48(4):321-337. doi:10.1007/s40264-024-01505-6

BibTeX
@article{Golder2025,
  author = {Golder, Su and Xu, Dongfang and O'Connor, Karen and Wang, Yunwen and Batra, Mahak and Hernandez, Graciela Gonzalez},
  title = {Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review},
  journal = {Drug Safety},
  year = {2025},
  volume = {48},
  number = {4},
  pages = {321--337},
  doi = {10.1007/s40264-024-01505-6}
}
Kostenlos starten →